ResMed (RMD) | Stock Overview & Key Data

US$248.58

0.64%

| Compare Stocks:

ResMed vs Intuitive Surgical ResMed vs Becton, Dickinson ResMed vs Alcon ResMed vs Cooper Companies ResMed vs West Pharmaceutical ResMed vs S&P 500 | Market

ResMed Performance Comparison

Loading chart data...

ResMed

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: US$246.20 High: US$249.97

on May 15, 2025

52 Week Range

Low: US$179.42 High: US$263.05

on June 24, 2024

on January 30, 2025

All-Time High: US$301.34 on September 6, 2021

Key Statistics

Market Cap i $35.9B

EPS i 8.91

P/E Ratio (TTM) i 27.50

Forward P/E i 23.81

P/B Ratio i 6.48

PEG Ratio i 23.81

Div. Yield i 0.84%

ROE i 25.81%

Beta i 0.783

Debt to Equity i 15.14

Financial Highlights

Profitability

Gross Margin i 59.33%

Operating Margin i 33.00%

Profit Margin i 26.15%

Returns and Earnings

Return on Assets (TTM) i 14.01%

Return on Equity (TTM) i 25.81%

EBITDA i $1.8B

Net Income (TTM) i $1.3B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i US$2.12

Estimated Dividend Yield i 0.87%

5 Year Average Dividend Yield i 0.83%

Last 12-Month Dividend Yield i 0.84%

Last 12-Month Dividend i US$2.07

% of Earnings Paid as Dividends i 23.23%

Dividend Date i June 12, 2025

Ex-Dividend Date i May 8, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
ResMed RMD	35.93B Large-cap	2.21%	16.12%	7.75%	5.84%	8.74%	13.72%	25.75%	54.05%
Intuitive Surgical ISRG	202.84B Mega-cap	4.09%	14.73%	-6.77%	6.17%	6.90%	40.40%	155.60%	198.48%
Becton, Dickinson BDX	49.37B Large-cap	2.57%	-14.73%	-23.48%	-23.49%	-23.94%	-27.08%	-31.70%	-26.18%
Alcon ALC	43.36B Large-cap	-8.55%	-4.09%	-1.98%	3.00%	5.07%	-1.33%	20.60%	43.81%
Cooper Companies COO	16.09B Large-cap	-1.77%	4.69%	-6.69%	-18.25%	-10.16%	-16.28%	-4.49%	13.37%
West Pharmaceutical WST	15.77B Large-cap	-1.89%	-0.86%	-0.15%	-33.01%	-35.84%	-40.76%	-29.94%	-0.36%

Ownership & Short Interest

Insider Ownership i 0.67%

Institutional Ownership i 63.40%

Shares Short i 9M

Short Ratio i 7.73

Short % of Shares Outstanding i 7.15%

Average 10-Day Volume i 834K

Average 90-Day Volume i 1M

ResMed Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in ResMed would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is RMD's 52-week high and low?

In the last 52 weeks, ResMed reached a high of US$263.05 (on January 30, 2025) and a low of US$179.42 (on June 24, 2024).

What is the market cap and P/E ratio for RMD?

Curious about ResMed's size and valuation? Its market capitalization stands at 35.93B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.50, and the forward P/E (looking ahead) is 23.81.

Does RMD pay dividends? If so, what's the yield?

Yes, ResMed is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.84%, and the company is expected to pay out US$2.12 per share over the coming year.

Who are ResMed's main competitors or similar companies to consider before investing?

When looking at ResMed, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Intuitive Surgical ISRG	202.84B	Healthcare	Medical Instruments & Supplies	40.40%	155.60%
Becton, Dickinson BDX	49.37B	Healthcare	Medical Instruments & Supplies	-27.08%	-31.70%
Alcon ALC	43.36B	Healthcare	Medical Instruments & Supplies	-1.33%	20.60%
Cooper Companies COO	16.09B	Healthcare	Medical Instruments & Supplies	-16.28%	-4.49%
West Pharmaceutical WST	15.77B	Healthcare	Medical Instruments & Supplies	-40.76%	-29.94%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for ResMed Inc.? (e.g., ROE, Debt/Equity)

To get a sense of ResMed's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 25.81%, the Debt to Equity ratio from the most recent quarter is 15.14, and its Gross Profit Margin stands at 59.33%.

What is the recent revenue and earnings growth for RMD?

Looking at ResMed's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.90%, and quarterly earnings saw a YoY growth of 21.50%.

How much of RMD stock is held by insiders and institutions?

Wondering who owns ResMed stock? Company insiders (like executives and directors) hold about 0.67% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 63.40%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.